ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 160 filers reported holding ANIKA THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $613,759 | -0.3% | 24,231 | -0.1% | 0.00% | 0.0% |
Q1 2024 | $615,889 | +7.9% | 24,248 | -3.8% | 0.00% | 0.0% |
Q4 2023 | $570,998 | +17.7% | 25,199 | -3.2% | 0.00% | 0.0% |
Q3 2023 | $484,945 | -63.9% | 26,031 | -49.7% | 0.00% | -50.0% |
Q2 2023 | $1,343,503 | +94713.2% | 51,713 | +4.8% | 0.00% | 0.0% |
Q1 2023 | $1,417 | +4.5% | 49,322 | +7.6% | 0.00% | 0.0% |
Q4 2022 | $1,356 | -99.9% | 45,825 | +1.1% | 0.00% | 0.0% |
Q3 2022 | $1,079,000 | +10.3% | 45,317 | +3.4% | 0.00% | +100.0% |
Q2 2022 | $978,000 | -9.5% | 43,815 | +1.8% | 0.00% | 0.0% |
Q1 2022 | $1,081,000 | -28.2% | 43,056 | +2.4% | 0.00% | -50.0% |
Q4 2021 | $1,506,000 | -16.4% | 42,043 | -0.7% | 0.00% | 0.0% |
Q3 2021 | $1,802,000 | -11.1% | 42,350 | -9.6% | 0.00% | -33.3% |
Q2 2021 | $2,027,000 | -2.0% | 46,824 | -7.7% | 0.00% | 0.0% |
Q1 2021 | $2,069,000 | -5.8% | 50,726 | +4.5% | 0.00% | 0.0% |
Q4 2020 | $2,197,000 | +42.1% | 48,545 | +11.1% | 0.00% | +50.0% |
Q3 2020 | $1,546,000 | -12.1% | 43,691 | -6.2% | 0.00% | -33.3% |
Q2 2020 | $1,758,000 | +21.2% | 46,584 | -7.1% | 0.00% | 0.0% |
Q1 2020 | $1,450,000 | -41.3% | 50,146 | +5.3% | 0.00% | -25.0% |
Q4 2019 | $2,470,000 | +0.2% | 47,639 | +6.1% | 0.00% | -20.0% |
Q3 2019 | $2,464,000 | +40.7% | 44,883 | +4.1% | 0.01% | +66.7% |
Q2 2019 | $1,751,000 | +36.2% | 43,118 | +1.4% | 0.00% | +50.0% |
Q1 2019 | $1,286,000 | -9.2% | 42,538 | +0.9% | 0.00% | -33.3% |
Q4 2018 | $1,417,000 | -6.9% | 42,172 | +16.8% | 0.00% | 0.0% |
Q3 2018 | $1,522,000 | +32.7% | 36,092 | +0.7% | 0.00% | +50.0% |
Q2 2018 | $1,147,000 | -31.9% | 35,848 | +5.8% | 0.00% | -50.0% |
Q1 2018 | $1,684,000 | -5.9% | 33,876 | +2.1% | 0.00% | 0.0% |
Q4 2017 | $1,789,000 | +8.8% | 33,181 | +17.1% | 0.00% | 0.0% |
Q3 2017 | $1,644,000 | +20.2% | 28,345 | +2.3% | 0.00% | +33.3% |
Q2 2017 | $1,368,000 | +14.0% | 27,720 | +0.3% | 0.00% | 0.0% |
Q1 2017 | $1,200,000 | +25.9% | 27,624 | +42.0% | 0.00% | +50.0% |
Q4 2016 | $953,000 | +5.2% | 19,455 | +2.7% | 0.00% | 0.0% |
Q3 2016 | $906,000 | -4.4% | 18,935 | +7.2% | 0.00% | -33.3% |
Q2 2016 | $948,000 | +14.1% | 17,670 | -4.9% | 0.00% | 0.0% |
Q1 2016 | $831,000 | +21.1% | 18,575 | +3.3% | 0.00% | +50.0% |
Q4 2015 | $686,000 | +28.5% | 17,990 | +7.2% | 0.00% | 0.0% |
Q3 2015 | $534,000 | -2.6% | 16,780 | +1.2% | 0.00% | 0.0% |
Q2 2015 | $548,000 | -19.4% | 16,589 | +0.5% | 0.00% | 0.0% |
Q1 2015 | $680,000 | +15.3% | 16,514 | +14.0% | 0.00% | 0.0% |
Q4 2014 | $590,000 | +8.5% | 14,489 | -2.4% | 0.00% | 0.0% |
Q3 2014 | $544,000 | -18.4% | 14,839 | +3.1% | 0.00% | 0.0% |
Q2 2014 | $667,000 | +8.6% | 14,389 | -3.8% | 0.00% | 0.0% |
Q1 2014 | $614,000 | +3.5% | 14,950 | -3.8% | 0.00% | 0.0% |
Q4 2013 | $593,000 | +90.7% | 15,540 | +19.6% | 0.00% | +100.0% |
Q3 2013 | $311,000 | +40.7% | 12,990 | +0.1% | 0.00% | 0.0% |
Q2 2013 | $221,000 | – | 12,972 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Portolan Capital Management | 217,105 | $10,058,000 | 2.20% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 284,393 | $13,175,000 | 0.88% |
AMI ASSET MANAGEMENT CORP | 183,494 | $8,501,000 | 0.84% |
CAPITAL MANAGEMENT CORP /VA | 49,765 | $2,306,000 | 0.74% |
TFS CAPITAL LLC | 105,839 | $4,904,000 | 0.39% |
Baltimore-Washington Financial Advisors, Inc. | 24,390 | $1,130,000 | 0.35% |
OBERWEIS ASSET MANAGEMENT INC/ | 27,600 | $1,279,000 | 0.32% |
Stephens Investment Management Group LLC | 192,650 | $8,925,000 | 0.27% |
THOMPSON SIEGEL & WALMSLEY LLC | 263,622 | $12,214,000 | 0.24% |
DIKER MANAGEMENT LLC | 21,200 | $982,000 | 0.22% |